The US issued an emergency use authorization for the first self-administered rapid coronavirus test on Tuesday, as other states of the country increase restrictions in attempt to hold the COVID-19 surge.
The Food and Drug Administration approved a testing kit of people of 14 and older whom doctors suspect have COVID-19. The test which is by the prescription only gives results of a test in 30 minutes.
“The FDA authorized that the first COVID-19 test that’s fully self-administered and gives results at home. It is an important advancement underscoring our commitment to expanding test access.”
The authorization is an at-home nasal sample kit by Lucira Health. Users collect a sample with the nasal swab which is included in the kit then put the sample in a small vial.
The vial is inserted into a small that test the sample. A light up display shows up on the device in a range of (20-30) mins.
The test kit is designed to be affordable and it is intended to cost less than $50 according to the Lucira Health Website.
The FDA has previously approved at-home COVID-19 tests, giving green light in late April and early May to two nasal sample collection kits and one saliva sample collection kit.
But samples from the sample testing kits had to be sent to a lab for processing instead of giving results at home.
While the Lucira test kit provides results on the spot, it isn’t cheap and rapid and antigen test to some researchers have called to use large scale production screening.
As of latest the US has recorded over 11,367,543 coronavirus cases with 248,429 deaths according to John Hopkins University.
This is sofa the country with most COVID-19 cases.